title: Combination of serum markers related to several mechanisms in Alzheimer's disease.
abstract: Alzheimer's disease (AD) probably involves several pathobiochemical mechanisms and this may be reflected by changes in different serum components. The present study investigated whether the combined analysis of serum molecules related to different mechanisms improves the discrimination of AD patients from healthy controls. Serum of patients with AD was analyzed for a broad spectrum of marker molecules, including 11 inflammatory proteins, 12 sterol intermediates and phytosterols, 2 brain-specific proteins and 4 constituents involved in homocysteine homeostasis. The serum molecule concentrations were combined in a logistic regression model, using a forward stepwise inclusion mode. The results showed that the combination of interleukin-6 (IL-6) receptor, protein alpha1 fraction, cysteine and cholesterol concentrations improved the discrimination between AD patients and healthy controls compared to the single markers. In conclusion, the results of this study have shown that the complex pathology in AD is reflected in a pattern of altered serum concentrations of several marker molecules related to several pathobiochemical mechanisms.
authors.affiliation: Department of Psychiatry and Neuropsychology, European Graduate School of Neuroscience (Euron), Universiteit Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. c.teunissen.cell@med.vu.nl
authors.forename: C E
authors.initials: CE
authors.lastname: Teunissen
authors.forename: D
authors.initials: D
authors.lastname: Lütjohann
authors.forename: K
authors.initials: K
authors.lastname: von Bergmann
authors.forename: F
authors.initials: F
authors.lastname: Verhey
authors.forename: F
authors.initials: F
authors.lastname: Vreeling
authors.forename: A
authors.initials: A
authors.lastname: Wauters
authors.forename: E
authors.initials: E
authors.lastname: Bosmans
authors.forename: H
authors.initials: H
authors.lastname: Bosma
authors.forename: M P J
authors.initials: MP
authors.lastname: van Boxtel
authors.forename: M
authors.initials: M
authors.lastname: Maes
authors.forename: J
authors.initials: J
authors.lastname: Delanghe
authors.forename: H J
authors.initials: HJ
authors.lastname: Blom
authors.forename: M M
authors.initials: MM
authors.lastname: Verbeek
authors.forename: P
authors.initials: P
authors.lastname: Rieckmann
authors.forename: C
authors.initials: C
authors.lastname: De Bruijn
authors.forename: H W M
authors.initials: HW
authors.lastname: Steinbusch
authors.forename: J
authors.initials: J
authors.lastname: de Vente
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D000544:Alzheimer Disease / Q000097:blood* / Q000503:physiopathology; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D002784:Cholesterol / Q000097:blood*; D003545:Cysteine / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006888:Hydroxycholesterols / Q000097:blood; D015850:Interleukin-6 / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D019636:Neurodegenerative Diseases / Q000097:blood; D010300:Parkinson Disease / Q000097:blood; D012016:Reference Values; D044967:Serum; D013261:Sterols / Q000097:blood; D000514:alpha 1-Antichymotrypsin / Q000097:blood*
chemical_list: D015415:Biomarkers; D006888:Hydroxycholesterols; D015850:Interleukin-6; D013261:Sterols; D000514:alpha 1-Antichymotrypsin; C044563:24-hydroxycholesterol; D002784:Cholesterol; D003545:Cysteine